Rheumatoid arthritis associated to fibromyalgia: factors associated with active synovitis and a proposal of an algorithm for management


fibromyalgia, synovitis, ultrasound, activity.

How to Cite

Miladi, S., BEN AYED, H., Makhlouf, Y., Faz, A., Boussâa, H., Leith, Z., Abdelghani, K. B., & Laatar, A. (2024). Rheumatoid arthritis associated to fibromyalgia: factors associated with active synovitis and a proposal of an algorithm for management. Rheumatology (Bulgaria), 32(1), 12-21. https://doi.org/10.35465/32.1.2024.pp12-21


Introduction: Recent studies have shown that ultrasound (US) assessment of disease activity in rheumatoid arthritis (RA) with associated fibromyalgia (FM) before disease-modifying antirheumatic drug escalation is primordial. The goal of this study was to assess the correlation between clinical and US disease activity in RA patients with concomitant FM comparatively to RA patients without FM. Specifically, we aimed to identify the predictive factors of detection of active US-synovitis. Methods: We conducted a cross-sectional study that included patients with diagnosis of RA (ACR/EULAR 2010 criteria) with and without concomitant FM (ACR 2016). US-detected synovitis was defined and scored 0-3 using the OMERACT scoring system at the joint level for both grey-scale (GS) and Doppler power (DP). Multiple linear regression analysis performed, adjusting for clinical and demographic variables. Results: Eighty patients distributed into 40 patients in each group were recruited. No significant difference was observed between the groups in regards to mean DAS28 and the three-variables (DAS28 V3). Multiple linear regression showed that in RA+FM group US synovitis detection was positively associated with male gender (B=0.29, p=0.04) and with the DAS28 V3 (B=0.87, p=0.014), and negatively associated with the patient global assessment (PGA) (B=-0.49, p=0.004). Doppler activity was positively associated with the DAS28 V3 (B=0.51,p=0.002) and with the physician global assessment (B=0.55, p=0.02), negatively associated with the PGA (B=-0.65, p=0.005). Conclusion: Our study showed that a high DAS28 V3 seems to be significantly associated with active US-synovitis in RA patients with comorbid FM.



  1. Binkiewicz-Glińska A, Bakuła S, Tomczak H, Landowski J, Ruckemann-Dziurdzińska K, Zaborowska-Sapeta K, et al. Fibromyalgia Syndrome - a multidisciplinary approach. Psychiatr Pol. 2015;49(4):801‑10.
  2. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 16 avr 2014;311(15):1547‑55.
  3. Zhao SS, Duffield SJ, Goodson NJ. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis. Best Pract Res Clin Rheumatol. juin 2019;33(3):101423.
  4. Durmaz Y, Ilhanli I. Rheumatoid arthritis activity scores in patients with and without fibromyalgia syndrome. Ann Saudi Med. 2021;41(4):246‑52.
  5. Mian AN, Chaabo K, Wajed J, Subesinghe S, Gullick NJ, Kirkham B, et al. Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord. 23 sept 2016;17(1):404.
  6. Pollard LC, Kingsley GH, Choy EH, Scott DL. Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatol Oxf Engl. mai 2010;49(5):924‑8.
  7. Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. mars 2018;21(3):639‑46.
  8. Miladi S, Ben Ayed H, Fazaa A, Boussaa H, Makhlouf Y, Souabni L, et al. Rheumatoid arthritis with concomitant fibromyalgia: The role of ultrasound in assessing disease activity. Musculoskeletal Care. 2023 May 8. doi: 10.1002/msc.1779. Epub ahead of print. PMID: 37157133.
  9. Mota LMH da, Cruz BA, Brenol CV, Pereira IA, Rezende-Fronza LS, Bertolo MB, et al. Guidelines for the drug treatment of rheumatoid arthritis. Rev Bras Reumatol. avr 2013;53(2):158‑83.
  10. da Silva Chakr RM, Brenol JCT, Behar M, Mendonça JA, Kohem CL, Monticielo OA, et al. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study. PloS One. 2015;10(3):e0118620.
  11. Ghib LJ, Tămaş MM, Damian LO, Felea I, Muntean LM, Rednic N, et al. The role of ultrasonography in assessing disease activity in patients with rheumatoid arthritis and associated fibromyalgia. Med Ultrason. sept 2015;17(3):339‑44.
  12. Silva Chakr RM da, Santos JC de O, Alves L da S, de Andrade NPB, Ranzolin A, Brenol CV. Ultrasound Assessment of Disease Activity Prevents Disease-Modifying Antirheumatic Drug (DMARD) Escalation and May Reduce DMARD-Related Direct Costs in Rheumatoid Arthritis With Fibromyalgia: An Exploratory Study. J Ultrasound Med Off J Am Inst Ultrasound Med. juill 2020;39(7):1271‑8.
  13. Dale J, Purves D, McConnachie A, McInnes I, Porter D. Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy. Arthritis Care Res. janv 2014;66(1):19‑26.
  14. D’Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA, et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open. 2017;3(1):e000428.
  15. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. sept 2010;62(9):2569‑81.
  16. El Meidany YM, El Gaafary MM, Ahmed I. Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine. juin 2003;70(3):195‑202.
  17. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. déc 2016;46(3):319‑29.
  18. Al Maqbali M, Hughes C, Gracey J, Rankin J, Hacker E, Dunwoody L. Psychometric Properties of the Arabic Version of the Functional Assessment of Chronic Illnesses Therapy-Fatigue in Arabic Cancer Patients. J Pain Symptom Manage. janv 2020;59(1):130-138.e2.
  19. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S154-162.
  20. Terkawi AS, Tsang S, AlKahtani GJ, Al-Mousa SH, Al Musaed S, AlZoraigi US, et al. Development and validation of Arabic version of the Hospital Anxiety and Depression Scale. Saudi J Anaesth. mai 2017;11(Suppl 1):S11‑8.
  21. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S100-108.
  22. Madsen OR. Is DAS28-CRP with three and four variables interchangeable in individual patients selected for biological treatment in daily clinical practice? Clin Rheumatol. déc 2011;30(12):1577‑82.
  23. Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, et al. OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On. J Rheumatol. oct 2019;46(10):1388‑93.
  24. Bezzaouha A, Bouamra A, Ammimer A, Ben Abdelaziz A. Non-parametric tests on SPSS to compare two or more means on matched samples. Tunis Med. déc 2020;98(12):932‑41.
  25. Skelly AC, Dettori JR, Brodt ED. Assessing bias: the importance of considering confounding. Evid-Based Spine-Care J. févr 2012;3(1):9‑12.
  26. Deming WE, Stephan FF. On a Least Squares Adjustment of a Sampled Frequency Table When the Expected Marginal Totals are Known. Ann Math Stat. 1940;11(4):427‑44.
  27. Guermazi M, Ghroubi S, Sellami M, Elleuch M, Feki H, André E, et al. [Fibromyalgia prevalence in Tunisia]. Tunis Med. sept 2008;86(9):806‑11.
  28. Alzabibi MA, Shibani M, Alsuliman T, Ismail H, Alasaad S, Torbey A, et al. Fibromyalgia: epidemiology and risk factors, a population-based case-control study in Damascus, Syria. BMC Rheumatol. 31 oct 2022;6(1):62.
  29. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol. déc 1983;10(6):965‑8.
  30. Lee YC, Lu B, Boire G, Haraoui B, Hitchon CA, Pope JE, et al. Incidence and Predictors of Secondary Fibromyalgia in an Early Arthritis Cohort. Ann Rheum Dis. juin 2013;72(6):949‑54.
  31. Chakr RM da S, Brenol C, Ranzolin A, Bernardes A, Dalosto AP, Ferrari G, et al. Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol. 2017;57(5):403‑11.
  32. Salaffi F, Gerardi MC, Atzeni F, Batticciotto A, Talotta R, Draghessi A, et al. The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int. déc 2017;37(12):2035‑42.
  33. Leffler AS, Kosek E, Lerndal T, Nordmark B, Hansson P. Somatosensory perception and function of diffuse noxious inhibitory controls (DNIC) in patients suffering from rheumatoid arthritis. Eur J Pain Lond Engl. 2002;6(2):161‑76.
  34. Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, et al. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. déc 2007;56(12):4015‑23.
  35. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci Off J Soc Neurosci. 14 mai 2008;28(20):5189‑94.
  36. Basu N, Kaplan CM, Ichesco E, Larkin T, Harris RE, Murray A, et al. Neurobiologic Features of Fibromyalgia Are Also Present Among Rheumatoid Arthritis Patients. Arthritis Rheumatol Hoboken NJ. juill 2018;70(7):1000‑7.
  37. Bernardes M, Vieira T, Lucas R, Pereira J, Costa L, Simões-Ventura F, Martins MJ. Serum serotonin levels and bone in rheumatoid arthritis patients. Rheumatol Int. 2017 Nov;37(11):1891-1898. doi: 10.1007/s00296-017-3836-9.
  38. Shresher NM, Mohamed AE, Elshahaly MH. Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis. Rheumatol Int. oct 2019;39(10):1703‑10.
  39. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings. J Pain Off J Am Pain Soc. mai 2009;10(5):447‑85.
  40. Ranzolin A, Brenol JCT, Bredemeier M, Guarienti J, Rizzatti M, Feldman D, et al. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum. 15 juin 2009;61(6):794‑800.
  41. Vander Cruyssen B, Durez P, Westhovens R, Vastesaeger N, Geldhof A, De Keyser F. Response to the commentary « Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician’s mind ». Arthritis Res Ther. 2006;8(6):406.
  42. Bellis E, Scirè CA, Carrara G, Adinolfi A, Batticciotto A, Bortoluzzi A, et al. Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology. Rheumatol Oxf Engl. oct 2016;55(10):1826‑36.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Download data is not yet available.